Perrigo Receives FDA Tentative Approval For Generic Equivalent To PrandinPerrigo Co. (Nasdaq: PRGO) announced that it has received tentative approval from the United States Food & Drug Administration for its abbreviated new drug application for repaglinide tablets, the generic equivalent to Prandin Tablets.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen